Tata Chemicals / Q1-FY27

TATACHEM Q1 FY27 earnings call.

A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Watch2026-07-12Back to TATACHEM

Revenue

₹4,255 Cr

verified against source

Revenue YoY

14%

reported change

EBITDA

Pending

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
Revenue (₹ Cr)PositiveWatchNegative
3 actual records
Actual quarterly Revenue (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q2 FY26: 3,877 · Watch source sentiment · 2025-10-28Q2 FY26Q3 FY26: 3,550 · Negative source sentimentQ3 FY26Q1 FY27: 4,255 · Watch source sentiment · 2026-07-12Q1 FY274,2553,550
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Tata Chemicals delivered resilient Q1 FY27 results amid challenging industrial conditions, with consolidated revenue up 14% YoY driven by volume growth across Living Essentials and Farm segments. Standalone performance was notably strong: revenue +10%, EBITDA +35%, PAT from continuing operations +12%. The primary headwind remains soda ash (Industrial Essentials ~50% of revenue), facing severe Chinese export competition with prices at $160-180 FOB, near cash cost levels for Chinese producers. China inventories reached record 1.73M tonnes with no rationalization announced. India took a Rs 2,000/tonne price increase with quarterly contract reviews pending. Segment reclassification from Basic Chemistry/Specialty Products to Living Essentials (salt, bicarbonate, prebiotics) and Farm Essentials (crop protection) better reflects strategic direction toward de-commoditization and non-cyclical businesses. Sodium ion battery pilot testing ongoing for stationary/storage applications with 6-9 month piloting timeline. Net debt reduced by Rs 300 crore via land and share sales. Key risks: prolonged China oversupply, Middle East geopolitical costs (fuel, logistics), Kenya HFO pricing, and India limestone import costs beyond October.

Colored figures show movement against the previous available record.

Guidance to track

  • Annualized capex will be around the depreciation number; management targets staying below that through the year for all lined-up investments.
  • IBSED 82.5 capacity salt plant in Hazira should get operational by end of FY27, with market supply starting Q1 FY28.
  • Both South India silica expansion (210 KT) and 50 KTP plant have 24-month execution timelines, targeting operational start in early FY28.
  • Management estimates sustainable EBITDA margin for India business at 32-33%, acknowledging Q1 margin may face cost pressure next quarter from higher coal and logistics costs.

Risks flagged

  • Chinese producers operating at high utilization with all-time high inventories; no supply curtailments announced. SE Asia pricing at break-even levels may persist through the year unless rationalization occurs.
  • Kenya HFO hedging expires October; India limestone imports from Middle East face elevated costs if conflict persists; US logistics costs remain an open item for customer pass-through.
  • IMAS (Morocco JV) did not produce during Q1 due to high sulfur prices, contributing to negative associate income. Only recently resumed operations with profitability outlook uncertain.
  • Multiple analysts pressed on margin sustainability and China competition; management acknowledged UK one-off losses (Rs 244 million) and prior period adjustments affecting profitability but gave limited specific guidance on recovery timeline.

Key quotes

  • We are fundamentally focused on making sure our portfolio moves in the direction... Our capital allocation will be done on that basis... We will be focusing our topics more towards what drives growth in food feed and pharma and also specific segments within the industrial essentials and try to decommoditize our portfolio as much as we can.
  • We have sold some land in Q1 and we sold some of the shares we holding and that contributed to the debt coming down in Q1.

Research modules

Go one layer deeper.